How can transcutaneous CO2 monitoring support your sleep lab?

Sentec transcutaneous technology overcomes limits of pulse oximetry, arterial blood draws and capnography with continuous CO2 monitoring that combines ease of use and patient comfort, with accurate values regardless of ventilation method or ventilation/perfusion (V/Q) mismatch, and product features designed for sleep care settings.

This paper explores the clinical utility of transcutaneous monitoring in the sleep lab as highlighted in the literature, covering: 

  • The presence of hypercapnia in pediatric and adult patients frequently seen in the sleep lab, which may not be detected if measuring oxygenation alone
  • How nighttime arterial blood gases are undesirable in the sleep lab due to pain and sleep interruption, while daytime ABGs do not reflect nighttime hypercapnia
  • How end-tidal CO2 is ill-suited for use in the sleep lab, as it relies on the condition of airway and mask compliance, underestimates PaCO2 in patients with V/Q mismatch (like COPD patients), and underrepresents PaCO2 in both pediatric and adult sleep lab patients
  • The demonstrated safety of Sentec’s digital transcutaneous monitoring for patients in the sleep lab
  • The indication of transcutaneous monitoring in the AAST, AASM, and AARC Clinical Practice Guidelines
transcutaneous monitoring in the sleep lab: clinical utility and impact

How can transcutaneous CO2 monitoring support your sleep lab?

Sentec transcutaneous technology overcomes many of the current limitations and challenges associated with CO2 measurement in the NICU by providing accurate, continuous, noninvasive CO2 values regardless of ventilation method or V/Q mismatch. Sentec transcutaneous monitoring provides consistent, independent CO2 measurement all while promoting neuroprotective efforts to deliver clustered care, protect skin integrity, and reduce the frequency of blood draws.

This paper explores the clinical utility of transcutaneous monitoring in the sleep lab as highlighted in the literature, covering:

  • The presence of hypercapnia in pediatric and adult patients frequently seen in the sleep lab, which may not be detected if measuring oxygenation alone
  • How nighttime arterial blood gases are undesirable in the sleep lab due to pain and sleep interruption, while daytime ABGs do not reflect nighttime hypercapnia
  • How end-tidal CO2 is ill-suited for use in the sleep lab, as it relies on the condition of airway and mask compliance, underestimates PaCO2 in patients with V/Q mismatch (like COPD patients), and underrepresents PaCO2 in both pediatric and adult sleep lab patients
  • The demonstrated safety of Sentec’s digital transcutaneous monitoring for patients in the sleep lab
  • The indication of transcutaneous monitoring in the AAST, AASM, and AARC Clinical Practice Guidelines

Meet the tCOM+

Developed with care, designed for confidence.

The tCOM+ offers continuous monitoring of tcPCO2, SpO2, and PR with a sleek new look and feel. This latest model includes significant software advances that improve workflow for providers, while continuing to support reduced blood draws and proactive ventilator management across care areas.

tCOM-device-angled

Stay up-to-date with Sentec


Related Posts

  • Whitepaper

    The Downsides & Limitations of Neonatal Blood Sampling

    Discover the hidden costs of neonatal blood sampling, including blood loss, pain, infection risk, and delayed detection of critical changes in the NICU.

  • Sentec Article

    Carbon Dioxide Monitoring in Neonatal Patients

    Learn why continuous carbon dioxide (CO₂) monitoring is critical in neonatal care. Discover how transcutaneous CO₂ monitoring helps clinicians detect fluctuations, support brain and lung protection, and reduce the need for invasive blood draws in NICU patients.

  • Sentec Article

    Protecting the Preterm Brain: The Role of CO2 in the First 72 Hours

    Learn how continuous transcutaneous CO₂ monitoring supports neuroprotection in preterm infants by helping maintain stable CO₂ levels during the critical first 72 hours.